✉news BusinessStartups first seen 15 h ago, last 11 h ago, peak #21
OpenAI leads $150M round for drug-reviving startup Biossil
OpenAI has led a $150 million funding round for Biossil, a startup working on reviving discontinued drugs. The deal marks a further push by OpenAI into applying its technology beyond core AI products, with biotech being a notable target area.
Why now: OpenAI's move into biotech investing is an unexpected expansion for a leading AI company, drawing wide attention.
Rank over time, top of the chart is #1. 4 snapshots from 15 h ago to 11 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/248746